The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2014

Filed:

Jun. 30, 2011
Applicants:

Thomas D. Perroud, San Jose, CA (US);

Ronald F. Renzi, Tracy, CA (US);

Oscar Negrete, Livermore, CA (US);

Mark R. Claudnic, Livermore, CA (US);

Inventors:

Thomas D. Perroud, San Jose, CA (US);

Ronald F. Renzi, Tracy, CA (US);

Oscar Negrete, Livermore, CA (US);

Mark R. Claudnic, Livermore, CA (US);

Assignee:

Sandia Corporation, Albuquerque, NM (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 25/08 (2006.01); C12M 1/42 (2006.01); B01L 3/00 (2006.01);
U.S. Cl.
CPC ...
B01L 3/502761 (2013.01); B01L 2300/0864 (2013.01); B01L 2300/0645 (2013.01); B01L 2200/0668 (2013.01); C12M 35/02 (2013.01);
Abstract

We have developed an microelectroporation device that combines microarrays of oligonucleotides, microfluidic channels, and electroporation for cell transfection and high-throughput screening applications (e.g. RNA interference screens). Microarrays allow the deposition of thousands of different oligonucleotides in microscopic spots. Microfluidic channels and microwells enable efficient loading of cells into the device and prevent cross-contamination between different oligonucleotides spots. Electroporation allows optimal transfection of nucleic acids into cells (especially hard-to-transfect cells such as primary cells) by minimizing cell death while maximizing transfection efficiency. This invention has the advantage of a higher throughput and lower cost, while preventing cross-contamination compared to conventional screening technologies. Moreover, this device does not require bulky robotic liquid handling equipment and is inherently safer given that it is a closed system.


Find Patent Forward Citations

Loading…